Chalkis Health Industry Co., Ltd (SHE:000972)
China · Delayed Price · Currency is CNY 3.570
+0.060 (1.71%)
Feb 13, 2026, 3:04 PM CST
Chalkis Health Industry Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 350.58 | 294.23 | 559.76 | 576.99 | 165.75 | 0.09 |
Other Revenue | 13.92 | 13.92 | 16.02 | 12.3 | 8.7 | 22.88 |
| 364.51 | 308.15 | 575.78 | 589.29 | 174.45 | 22.97 | |
Revenue Growth (YoY) | -31.30% | -46.48% | -2.29% | 237.79% | 659.61% | -89.23% |
Cost of Revenue | 653.96 | 531.45 | 430.61 | 434.61 | 180.74 | 62.51 |
Gross Profit | -289.45 | -223.29 | 145.17 | 154.68 | -6.29 | -39.54 |
Selling, General & Admin | 91.16 | 50.55 | 59.35 | 34.2 | 40.33 | 37.09 |
Research & Development | 0.11 | 1.98 | 0.73 | - | - | - |
Other Operating Expenses | 5.9 | 2.96 | 6.3 | 4.12 | 3.14 | 2.42 |
Operating Expenses | 24.4 | -23.88 | 80.8 | 100.73 | 74.89 | 49.72 |
Operating Income | -313.85 | -199.41 | 64.37 | 53.94 | -81.18 | -89.27 |
Interest Expense | -38.89 | -26.84 | -22.02 | -15.87 | -10.29 | -4.42 |
Interest & Investment Income | 0.33 | 0.32 | 1.91 | 0.84 | 0.1 | 0.1 |
Currency Exchange Gain (Loss) | 0.94 | 0.94 | 0.96 | 3.16 | -0.8 | -2.41 |
Other Non Operating Income (Expenses) | 9.29 | 0.55 | 1.34 | -11.03 | -7.87 | -168.62 |
EBT Excluding Unusual Items | -342.17 | -224.44 | 46.56 | 31.04 | -100.05 | -264.62 |
Gain (Loss) on Sale of Investments | - | - | - | -0 | - | - |
Gain (Loss) on Sale of Assets | 2 | 0.74 | 40.57 | 0.22 | 0.23 | 0.02 |
Asset Writedown | -50.28 | - | - | -1.66 | -2.51 | -0.6 |
Legal Settlements | -0.2 | -0.2 | -0.58 | -0.03 | - | - |
Other Unusual Items | 52.48 | -8.74 | 22.82 | 1.8 | -4.54 | -0.03 |
Pretax Income | -338.18 | -232.64 | 109.37 | 31.38 | -106.87 | -265.22 |
Income Tax Expense | 2.8 | 0.26 | 0.22 | 5.29 | 0 | 1.5 |
Earnings From Continuing Operations | -340.97 | -232.9 | 109.15 | 26.08 | -106.87 | -266.72 |
Minority Interest in Earnings | 9.66 | 2.12 | -0.91 | 0 | 0.06 | 0.83 |
Net Income | -331.32 | -230.78 | 108.24 | 26.09 | -106.81 | -265.89 |
Net Income to Common | -331.32 | -230.78 | 108.24 | 26.09 | -106.81 | -265.89 |
Net Income Growth | - | - | 314.94% | - | - | - |
Shares Outstanding (Basic) | 772 | 771 | 771 | 870 | 763 | 782 |
Shares Outstanding (Diluted) | 772 | 771 | 771 | 870 | 763 | 782 |
Shares Change (YoY) | 0.05% | -0.02% | -11.27% | 13.96% | -2.44% | 57.17% |
EPS (Basic) | -0.43 | -0.30 | 0.14 | 0.03 | -0.14 | -0.34 |
EPS (Diluted) | -0.43 | -0.30 | 0.14 | 0.03 | -0.14 | -0.34 |
EPS Growth | - | - | 367.67% | - | - | - |
Free Cash Flow | -157.12 | -133.24 | -397.17 | 183.66 | -200.69 | -13.76 |
Free Cash Flow Per Share | -0.20 | -0.17 | -0.52 | 0.21 | -0.26 | -0.02 |
Gross Margin | -79.41% | -72.46% | 25.21% | 26.25% | -3.60% | -172.19% |
Operating Margin | -86.10% | -64.71% | 11.18% | 9.15% | -46.53% | -388.68% |
Profit Margin | -90.90% | -74.89% | 18.80% | 4.43% | -61.23% | -1157.76% |
Free Cash Flow Margin | -43.11% | -43.24% | -68.98% | 31.17% | -115.04% | -59.93% |
EBITDA | -280.71 | -162.95 | 105.27 | 98.72 | -35.54 | -42.31 |
EBITDA Margin | -77.01% | -52.88% | 18.28% | 16.75% | -20.37% | -184.21% |
D&A For EBITDA | 33.14 | 36.47 | 40.9 | 44.78 | 45.64 | 46.96 |
EBIT | -313.85 | -199.41 | 64.37 | 53.94 | -81.18 | -89.27 |
EBIT Margin | -86.10% | -64.71% | 11.18% | 9.15% | -46.53% | - |
Effective Tax Rate | - | - | 0.20% | 16.86% | - | - |
Revenue as Reported | 364.51 | 308.15 | 575.78 | 589.29 | 174.45 | 22.97 |
Advertising Expenses | - | 0.66 | 0.63 | 0.05 | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.